Stay updated with breaking news from Daptorum Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Aptorum Group Limited , a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune and infectious diseases, today provided a business update and...
Aptorum Group Limited , a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune diseases and infectious diseases, announced the results of its...
Aptorum Group Limited (NASDAQ:APM – Get Free Report) saw a large decrease in short interest in October. As of October 31st, there was short interest totalling 19,000 shares, a decrease of 6.9% from the October 15th total of 20,400 shares. Currently, 1.5% of the shares of the company are sold short. Based on an average […]
Aptorum Group Limited (NASDAQ:APM – Get Free Report) was the target of a large drop in short interest in September. As of September 15th, there was short interest totalling 29,300 shares, a drop of 66.7% from the August 31st total of 88,000 shares. Currently, 2.3% of the company’s stock are sold short. Based on an […]
Aptorum Group Limited , a clinical-stage biopharmaceutical company, announced that it has received an approval letter from the Nasdaq Stock Market LLC Listing Qualifications Department notifying... -Today at 02:58 am- MarketScreener